Anterogen Co., Ltd.
Records under this name other than the patents Anterogen Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 2 of 2 · Back to Anterogen Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,874,574 | Marker for detecting proliferation and treatment capacities of adipose-derived stem cell cultured in medium containing EGF or BFGF, and use thereof Formerly held Lapsed on the fee record Ended Jan 23, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 23, 2026 | From the USPTO record |
| US 7,297,538 | Encapsulated cell indicator system Formerly held Lapsed on the fee record Ended Nov 20, 2015 · From the USPTO record | Lapsed on the fee record | Ended Nov 20, 2015 | From the USPTO record |